Devices › Suture, absorbable, synthetic, polyglycolic acid
Device brand name · Suture absorbable synthetic
Vicryl Plus Antibacterial Polyglactin 910 Suture: medical device reports filed with FDA
852 reports name it, 2013–2017. Manufacturer given most often on reports: Ethicon. Product code GAM.
- 852
- device reports naming the brand
- 0% of all MAUDE reports · about 65 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 67.6%
- classified as malfunction
- 76.5% across the product code
- 0.1%
- classified as death, as reported
- 1 reports · not verified by FDA
852 medical device reports received by FDA name the brand "Vicryl Plus Antibacterial Polyglactin 910 Suture" (suture absorbable synthetic); the manufacturer given most often on reports is Ethicon; received from June 2013 to August 2017. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (67.6%), injury (32.2%) and death (0.1%); across all suture, absorbable, synthetic, polyglycolic acid reports (product code GAM) death is recorded in 0.2% and malfunction in 76.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are break (41%), needle, separation (36.4%) and other (for use when an appropriate device code cannot be identified) (7.9%). The patient problems coded most often are wound dehiscence, surgical procedure and reaction. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Vicryl Plus Antibacterial Polyglactin 910 Suture was received in the five years to August 2026; the latest was received in August 2017.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 56,946 reports carrying product code GAM. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Breakthe device broke | 349 | 41% | 36.3% |
| Needle, separation | 310 | 36.4% | 1.7% |
| Other (for use when an appropriate device code cannot be identified) | 67 | 7.9% | 2.6% |
| Reactiona reaction, type not specified | 20 | 2.3% | 1.1% |
| Bent | 15 | 1.8% | 0.2% |
| Implant extrusion | 12 | 1.4% | 0.2% |
| Tear, rip or hole in device packaging | 8 | 0.9% | 0.3% |
| Detachment of device component | 3 | 0.4% | 1% |
| Component incompatible | 2 | 0.2% | 0.1% |
| Unsealed device packaging | 2 | 0.2% | 0% |
| Device markings/labelling problema problem with the device markings or label | 1 | 0.1% | 0.6% |
| Incomplete or missing packaging | 1 | 0.1% | 0% |
| Insufficient device problem information | 1 | 0.1% | 1.1% |
| Migration or expulsion of device | 1 | 0.1% | 0.1% |
| Sterility | 1 | 0.1% | 0% |
| Tears, rips, holes in device, device material | 1 | 0.1% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Wound dehiscencea wound reopened | 63 | 7.4% |
| Surgical procedure | 45 | 5.3% |
| Reactiona reaction, type not specified | 40 | 4.7% |
| Impaired healingslow healing | 34 | 4% |
| Device embedded in tissue or plaque | 28 | 3.3% |
| Nonresorbable materials, unretrieved in body | 24 | 2.8% |
| Treatment with medication(s) | 23 | 2.7% |
| Inflammationinflammation | 20 | 2.3% |
| Surgical procedure, additional | 19 | 2.2% |
| Organ dehiscence | 17 | 2% |
| Scar tissue | 16 | 1.9% |
| Painpain, site not specified | 13 | 1.5% |
| Extrusion | 12 | 1.4% |
| Drainage | 10 | 1.2% |
| Scarring | 9 | 1.1% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Vicryl Plus Antibacterial Polyglactin 910 Suture | Product code GAM | All MAUDE reports |
|---|---|---|---|
| Reports | 852 | 56,946 | 26,136,888 |
| Share of that pool | — | 1.5% | 0% |
| Classified as death, per 1,000 reports | 1 | 2 | 9 |
| Classified as injury | 32.2% | 23% | 36.2% |
| Classified as malfunction | 67.6% | 76.5% | 62.3% |
| Filed by the manufacturer | 100% | 98% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code GAM
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Polysorb | 5,410 | 1,836 | 0% |
| V-Loc 180 | 3,447 | 678 | 0% |
| Vicryl Polyglactin 910 Suture Unknown Product | 2,373 | 210 | 1.2% |
| Coated VICRYL (polyglactin 910) Suture | 1,930 | 20 | 0.5% |
| Maxon | 1,809 | 309 | 0% |
| Biosyn | 1,681 | 261 | 0% |
| V-Loc 90 | 1,378 | 226 | 0% |
| VICRYL Polyglactin 910 Suture | 1,262 | 74 | 0.1% |
| Vcl+ Ud 27in 5-0 S/A Tf | 1,125 | 158 | 0.1% |
| Coated VICRYL | 978 | 851 | 0% |
| Coated Vicryl Plus Antibacterial Polyglactin 910 | 724 | 0 | 0% |
| Vcl+ Ud 18in 5-0 S/A P-3 Prm Mp | 518 | 126 | 0% |
| Unknown VLoc Product | 413 | 39 | 3.6% |
| Caprosyn | 399 | 94 | 0% |
| Vcl+ Vio 36in 2-0 S/A Ct-1 | 399 | 42 | 0.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Vicryl Plus Antibacterial Polyglactin 910 Suture reports
How many FDA reports name Vicryl Plus Antibacterial Polyglactin 910 Suture?
852 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (67.6%), injury (32.2%) and death (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
break (41%), needle, separation (36.4%), other (for use when an appropriate device code cannot be identified) (7.9%), reaction (2.3%) and bent (1.8%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Vicryl Plus Antibacterial Polyglactin 910 Suture was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.